New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
18:44 EDTZ, CHUY, JAZZ, ZAGG, CYTX, XXIA, PBPB, ATVI, ZGNX, TWX, SCTY, FSLR, NYMT, DRYS, FOXAOn The Fly: After Hours Movers
UP AFTER EARNINGS: Zogenix (ZGNX), up 8.21%... Zagg (ZAGG), up 8.9%... DryShips (DRYS), up 7%... Activision Blizzard (ATVI), up 3.1%... Jazz Pharmaceuticals (JAZZ), up 3%... New York Mortgage Trust (NYMT), up 1.4%... Potbelly (PBPB), up 1% after reporting second quarter results and announcing a $35M share repurchase program. DOWN AFTER EARNINGS: Chuy's Holdings (CHUY), down 6% after reporting second quarter results below analyst estimates and lowering fiscal 2014 guidance... First Solar (FSLR), down 4.1%... Ixia (XXIA), down 1.4% after reporting preliminary first quarter EPS below analyst estimates... Zillow (Z), down marginally after reporting quarterly results. ALSO LOWER: SolarCity (SCTY), down 1.4% after First Solar reported second quarter results... Cytori Therapeutics (CYTX), down 28.6% after announcing that it has placed enrollment in the ATHENA and ATHENA II trials on clinical hold. NOTABLE: Twenty-First Century Fox (FOXA), up 7.8% after announcing that it has withdrawn its proposal to acquire Time Warner (TWX) and announcing a $6B share repurchase program... Time Warner is trading down 9.8%.
News For ZGNX;ZAGG;DRYS;ATVI;JAZZ;NYMT;PBPB;CHUY;FSLR;XXIA;Z;SCTY;CYTX;FOXA;TWX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 10, 2015
12:15 EDTTWXTime Warner volatility at low end of historic range
Time Warner April call option implied volatility is at 17, May weekly is at 21, July is at 20; compared to its 26-week average of 22 according to Track Data, suggesting decreasing price movement into the expected release of Q1 results on April 29.
06:48 EDTTWX, ATVITime Warner, Legos to market figures that can be brought to life, NY Times says
Subscribe for More Information
April 9, 2015
09:47 EDTTWXDISH's Sling TV adds HBO programming to lineup
Subscribe for More Information
08:16 EDTSCTYBofA/Merrill sees catalysts ahead for SolarCity
Subscribe for More Information
April 8, 2015
16:04 EDTPBPBPotbelly appoints Michael Coyne as CFO
Potbelly announced the appointment of Michael Coyne as its new CFO, effective May 1. Coyne will oversee all financial functions and will also be charged with positively impacting Potbelly's analytical, productivity, and risk assessment capabilities. Most recently, Coyne served as SVP, Small Business at CNA Financial.
15:00 EDTCYTXCytori CEO spinning 'fairy-tale story' to support company, TheStreet says
Subscribe for More Information
14:50 EDTTWXGoogle plans ad-free YouTube subscription service, Bloomberg says
Google (GOOG) is planning to launch a YouTube subscription service as early as this year, reports Bloomberg, citing a person with knowledge of the matter and a YouTube letter sent to certain content creators on the site. The new paid version of the site will be free of ads and may include a type of offline access to YouTube. Bloomberg notes that the move will put the streaming site into closer competition with Netflix (NFLX), Time Warner's (TWX) HBO Now, and similar paid streaming services. Reference Link
14:42 EDTFSLRAnalyst says solar to be disruptive in some markets by 2018
Subscribe for More Information
11:29 EDTATVIOptions with increasing implied volatility
Subscribe for More Information
10:41 EDTFOXAVivendi seeks 'transformational' deals, has 'no interest' in buying Sky, FT says
Vivendi (VIVHY) CEO Arnaud de Puyfontaine says the company is currently considering "transformational transactions," The Financial Times reports. The executive says Vivendi "will not do deals just because we can do them," and will seek acquisition targets "with intrinsic value." The CEO also notes that Vivendi has "no interest" in buying Sky (SKYAY) and says that ITV is "too expensive." Reference Link
07:43 EDTFSLRFirst Solar Yield Co. could add $5-$15 per share, says FBR Capital
Subscribe for More Information
07:22 EDTFSLRSeasonality reason for NJ solar pricing softness, says UBS
UBS said the recent weakness in the New Jersey solar market is due to seasonal factors including a deceleration in the pace of the state's solar renewable target alongside the declining cost structure of solar. Publicly traded companies in the space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).
07:09 EDTFSLRSolar plus storage to be cheaper than competition in 2018, says Bernstein
Subscribe for More Information
April 7, 2015
18:26 EDTFOXAVivendi says not in talks to acquire Sky, Bloomberg reports
Vivendi (VIVHY) denied an earlier report by Reuters that it may look to acquire Sky (SKYAY), Bloomberg says. Reference Link
15:31 EDTFOXAVivendi considering potential acquisition of Sky, Reuters reports
Subscribe for More Information
12:50 EDTTWXHBO NOW available to Apple and Optimum Online customers
Subscribe for More Information
12:36 EDTATVIOptions with increasing implied volatility
Subscribe for More Information
10:10 EDTJAZZJazz patent on Xyrem latest to be challenged by Kyle Bass
Subscribe for More Information
08:02 EDTCYTXCytori Therapeutics granted orphan drug status for cellular therpeutic in EU
Cytori Therapeutics announced that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products, has designated Cytori’s ECCS-50 cellular therapeutic as an orphan medicinal product for the treatment of scleroderma. This designation marks the first autologous adipose derived cell therapy for scleroderma granted orphan status in the European Union. Cytori is currently working with leading scleroderma centers in France led by the Assistance Publique des Hôpitaux de Marseille to begin a 40 patient EU pivotal trial called SCLERADEC-II. The trial is a follow-up controlled trial to the first SCLERADEC trial published last August. If successful, this trial would potentially lead to EMA approval of Cytori’s lead therapeutic for this indication in the EU, as an ATMP or Advanced Therapy Medicinal Product. Cytori recently received FDA approval for a phase 3 clinical trial with our ECCS-50 therapeutic in 80 patients with scleroderma associated hand dysfunction. This US clinical trial is currently planned to begin enrolling this year and has recently been granted FDA approval to expand the number of centers from 12 to 20 sites. This US clinical data could also be useful to support regulatory approvals and reimbursement in the EU as well as other global markets.
05:10 EDTFOXADisney, Lucasfilm, 20th Century Fox announce Star Wars digital movie collection
As anticipation builds for the December release of Star Wars: The Force Awakens, Walt Disney Studios (DIS), Lucasfilm Ltd., and 20th Century Fox (FOX, FOXA) announced the upcoming release of The Star Wars Digital Movie Collection. For the first time ever, all six epic films in the Saga, from The Phantom Menace to Return of the Jedi, will be available on Digital HD globally beginning Friday, April 10.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use